Literature DB >> 4213282

Outpatient intravenous medications in the management of cystic fibrosis.

R W Rucker, G M Harrison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4213282

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  36 in total

1.  Home intravenous therapy: Accessibility for Canadian children and youth.

Authors:  Dl Moore; R Bortolussi
Journal:  Paediatr Child Health       Date:  2011-02       Impact factor: 2.253

Review 2.  Economics of home intravenous services.

Authors:  N D Thickson
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

3.  What Medicare Is Missing.

Authors:  Sara Keller; Peter Pronovost; Sara Cosgrove
Journal:  Clin Infect Dis       Date:  2015-09-03       Impact factor: 9.079

4.  Improved diabetic prognosis following telecommunication and graphical processing of diabetic data.

Authors:  E K Shultz; A Bauman; M Hayward; D Rodbard; R Holzman
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1991

5.  Outpatient parenteral antibiotic therapy in an academic practice in Rhode Island.

Authors:  Francine Touzard Romo; Brian Resnick; Mildred Perez-Cioe; Timothy P Flanigan; Erna M Kojic; Curt G Beckwith
Journal:  R I Med J (2013)       Date:  2014-01-05

6.  In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.

Authors:  Cedric Jacqueline; Jocelyne Caillon; Olivier Grossi; Virginie Le Mabecque; Anne-Françoise Miegeville; Denis Bugnon; Eric Batard; Gilles Potel
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

7.  Outpatient parenteral antimicrobial therapy.

Authors:  Kevin B Laupland; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

8.  Factors associated with successful completion of outpatient parenteral antibiotic therapy in an area with a high prevalence of multidrug-resistant bacteria: 30-day hospital admission and mortality rates.

Authors:  Thais Cristina Garbelini Salles; Santiago Grau Cerrato; Tatiana Fiscina Santana; Eduardo Alexandrino Medeiros
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

Review 9.  Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.

Authors:  Christian Krauth; Noushin Jalilvand; Tobias Welte; Reinhard Busse
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting.

Authors:  J Kieran; A O'Reilly; J Parker; S Clarke; C Bergin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-21       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.